Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020

Published by Statista Research Department, Sep 8, 2016
This statistic shows the cumulative potential biosimilars market in EU-5 countries and the U.S. between 2016 and 2020. The addressable biosimilars market in the United States in this time range is estimated to be worth almost 250 billion euros.

Cumulative potential biosimilars market in EU-5 countries and the U.S. between 2016 and 2020 (in billion euros)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2016

Region

United States, EU

Survey time period

as of December 2015

Supplementary notes

Addressable market is calculated based on projected growth of originator market without biosimiliar entry. Growth rate is based on historical growth and analogue analysis.
Conversion rate: 1 USD = 0.916562 EUR (01/20/2016).

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Generics and biosimilars "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu